Seattle Genetics, Inc. SGEN today announced the pricing of an
underwritten public offering of 11,707,318 shares of its common stock at
a price to the public of $41.00 per share. All of the shares are being
sold by Seattle Genetics. The gross proceeds to Seattle Genetics from
the offering, before deducting the underwriting discounts and
commissions and other offering expenses, are expected to be
approximately $480 million. The offering was upsized by 20 percent from
the originally anticipated gross offering amount of $400 million. The
offering is expected to close on or about September 16, 2015, subject to
customary closing conditions. In addition, Seattle Genetics has granted
the underwriters of the offering a 30-day option to purchase up to an
additional
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in